5ht lesions produced by 5,7-dihydroxytryptamine ( 5,7-dht ) enhanced the behavioural response produced by the 5ht receptor agonist 5-methoxy-n , n-dimethyltryptamine ( 5-meodmt ) while decreasing the locomotor hyperactivity observed following administration of the trh analogue cg 3509 but having no effect on the reversal of pentobarbitone sleep-time produced by cg 3509 .
C0004927
behavioural
C0037313
sleep